Ameritas Investment Partners’s Aquestive Therapeutics AQST Stock Holding History

Ameritas Investment Partners’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.8K	Buy	9,800 +2,524	+35%	+$10.6K	﹤0.01%	2367
2026 Q1	$30.2K	Hold	7,276	–	–	﹤0.01%	2385
2025 Q4	$47K	Hold	7,276	–	–	﹤0.01%	2173
2025 Q3	$40.7K	Hold	7,276	–	–	﹤0.01%	2294
2025 Q2	$24.1K	Hold	7,276	–	–	﹤0.01%	2575
2025 Q1	$21.1K	Hold	7,276	–	–	﹤0.01%	2529
2024 Q4	$25.9K	Hold	7,276	–	–	﹤0.01%	2520
2024 Q3	$36.2K	Hold	7,276	–	–	﹤0.01%	2373
2024 Q2	$18.9K	Buy	+7,276	New	+$24.3K	﹤0.01%	2640
2021 Q2	–	Sell	-1,755	Closed	-$9K	–	3053
2021 Q1	$9K	Hold	1,755	–	–	﹤0.01%	2884
2020 Q4	$9K	Hold	1,755	–	–	﹤0.01%	2813
2020 Q3	$9K	Hold	1,755	–	–	﹤0.01%	2749
2020 Q2	$9K	Buy	+1,755	New	+$8.08K	﹤0.01%	2759
2019 Q2	–	Sell	-400	Closed	-$3K	–	3047
2019 Q1	$3K	Hold	400	–	–	﹤0.01%	2909
2018 Q4	$3K	Hold	400	–	–	﹤0.01%	2904
2018 Q3	$7K	Buy	+400	New	+$6.59K	﹤0.01%	2909

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Ameritas Investment Partners's AQST Position: Q2 2026 in Review

Ameritas Investment Partners increased its Aquestive Therapeutics (AQST) stake by 35% in Q2 2026, buying an estimated $10.6K and bringing the position to 9,800 shares worth $40.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2367.

Ameritas Investment Partners first reported a position in AQST in Q3 2018 and has held it in 16 quarters since. The position peaked at $47K in Q4 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Ameritas Investment Partners held 9,800 shares of Aquestive Therapeutics worth $40.8K as of Q2 2026.
Ameritas Investment Partners bought 2,524 Aquestive Therapeutics shares in Q2 2026, an estimated $10.6K.
Aquestive Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2367 holding.
Ameritas Investment Partners first reported a position in Aquestive Therapeutics in Q3 2018 and has held it in 16 quarters since.
Ameritas Investment Partners's Aquestive Therapeutics position peaked at $47K in Q4 2025.
184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.